Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of Medicine.
Deisseroth
A B
AB
U.T.M.D. Anderson Cancer Center, Department of Hematology, Houston 77030.
Kantarjian
H
H
Talpaz
M
M
Champlin
R
R
Reading
C
C
Andersson
B
B
Claxton
D
D
D000293:Adolescent; D000328:Adult; D015415:Biomarkers; D001773:Blood Cells / Q000166:cytology; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002985:Clinical Protocols; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008875:Middle Aged; D012190:Retroviridae; D014182:Transplantation, Autologous
D015415:Biomarkers